a public good project by the
Synthesis
Company
of California

© 2026

Maria Dimitrova | doi.page

0 works0 citations0 h-index

Maria Dimitrova

Medical University of Sofia(BG)

Publications by Year

Research Areas

Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life, Chronic Obstructive Pulmonary Disease (COPD) Research, Economic and Financial Impacts of Cancer, Hepatitis C virus research

Most-Cited Works

→ Policies for biosimilar uptake in Europe: An overview(2017)348 cited
→ Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins(2003)180 cited
→ The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications(2017)119 cited
→ The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures(2021)67 cited
→ Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses(2021)67 cited
→ Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries(2017)61 cited

→ Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy(2017)

58 cited

→ Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA(2019)46 cited

→ Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries(2022)45 cited

→ Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria(2020)41 cited